Jiaqiang Wang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Top Venues

Cancer management and research

Investigational new drugs

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jiaqiang Wang, Hong Ge, Zhichao Tian
Immunotherapy Plus Radiotherapy for the Treatment of Sarcomas: Is There a Potential for Synergism? OncoTargets and therapy 16 (2023)
Jiaqiang Wang, Shilei Gao, Yonghao Yang, Xu Liu, Peng Zhang, Shuping Dong, Xin Wang, Weitao Yao
Clinical Experience with Apatinib and Camrelizumab in Advance Clear Cell Sarcoma: A Retrospective Study. Cancer management and research 13 (2021)
Jiaqiang Wang, Shuping Dong, Jianpo Zhang, Shilei Gao, Zhehuang Li, Po Li, Junhui Yuan, Zhichao Tian
Undifferentiated Pleomorphic Sarcoma with Neoplastic Fever: A Retrospective Study. Cancer management and research 13 (2021)
Zhichao Tian, Jiaqiang Wang, Jinpo Yang, Peng Zhang, Xin Wang, Fan Zhang, Po Li, Weitao Yao
Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study. Investigational new drugs 39 (6) (2021)
Zhichao Tian, Huimin Liu, Fan Zhang, Liangyu Li, Xinhui Du, Chao Li, Jinpo Yang, Jiaqiang Wang
Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma. Investigational new drugs 38 (5) (2020)
Zhichao Tian, Yonghao Yang, Jinpo Yang, Peng Zhang, Fan Zhang, Xinhui Du, Chao Li, Jiaqiang Wang
Safety and Efficacy of PD-1 Inhibitors Plus Chemotherapy in Advanced Soft Tissue Sarcomas: A Retrospective Study. Cancer management and research 12 (2020)